DE60229971D1 - Zubereitungen zur reizhemmenden rosacea-behandlung - Google Patents

Zubereitungen zur reizhemmenden rosacea-behandlung

Info

Publication number: DE60229971D1
Authority: DE; Germany
Prior art keywords: rosacea; treating; components; skin; irritative
Prior art date: 2001-10-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60229971T

Other languages

English (en)

Inventor

Kenneth D Marenus

Neelam Muizzuddin

Daniel H Maes

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Color Access Inc

Original Assignee

Color Access Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-05

Filing date

2002-09-18

Publication date

2009-01-02

2002-09-18 Application filed by Color Access Inc filed Critical Color Access Inc

2009-01-02 Application granted granted Critical

2009-01-02 Publication of DE60229971D1 publication Critical patent/DE60229971D1/de

2022-09-19 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

241001303601 Rosacea Species 0.000 title abstract 7
201000004700 rosacea Diseases 0.000 title abstract 7
230000000622 irritating effect Effects 0.000 title 1
238000002360 preparation method Methods 0.000 title 1
FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 abstract 2
241000124001 Alcyonacea Species 0.000 abstract 1
AERBNCYCJBRYDG-UHFFFAOYSA-N D-ribo-phytosphingosine Natural products CCCCCCCCCCCCCCC(O)C(O)C(N)CO AERBNCYCJBRYDG-UHFFFAOYSA-N 0.000 abstract 1
244000269722 Thea sinensis Species 0.000 abstract 1
TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 abstract 1
239000002537 cosmetic Substances 0.000 abstract 1
230000003247 decreasing effect Effects 0.000 abstract 1
150000004676 glycans Chemical class 0.000 abstract 1
235000009569 green tea Nutrition 0.000 abstract 1
230000007794 irritation Effects 0.000 abstract 1
FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
AERBNCYCJBRYDG-KSZLIROESA-N phytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO AERBNCYCJBRYDG-KSZLIROESA-N 0.000 abstract 1
229940033329 phytosphingosine Drugs 0.000 abstract 1
229920001282 polysaccharide Polymers 0.000 abstract 1
239000005017 polysaccharide Substances 0.000 abstract 1
150000004492 retinoid derivatives Chemical class 0.000 abstract 1
229960004889 salicylic acid Drugs 0.000 abstract 1
230000035945 sensitivity Effects 0.000 abstract 1
208000024891 symptom Diseases 0.000 abstract 1
230000000699 topical effect Effects 0.000 abstract 1
229930007845 β-thujaplicin Natural products 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9717—Rhodophycota or Rhodophyta [red algae], e.g. Porphyra
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant

DE60229971T 2001-10-05 2002-09-18 Zubereitungen zur reizhemmenden rosacea-behandlung Expired - Lifetime DE60229971D1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/971,561 US6680062B2 (en)	2001-10-05	2001-10-05	Anti-irritating rosacea treatment
PCT/US2002/029722 WO2003030813A2 (en)	2001-10-05	2002-09-18	Anti-irritating rosacea treatment

Publications (1)

Publication Number	Publication Date
DE60229971D1 true DE60229971D1 (de)	2009-01-02

Family

ID=25518547

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60229971T Expired - Lifetime DE60229971D1 (de)	2001-10-05	2002-09-18	Zubereitungen zur reizhemmenden rosacea-behandlung

Country Status (9)

Country	Link
US (1)	US6680062B2 (de)
EP (1)	EP1441685B1 (de)
JP (2)	JP3921202B2 (de)
AT (1)	ATE414527T1 (de)
AU (1)	AU2002334601B2 (de)
CA (1)	CA2461941C (de)
DE (1)	DE60229971D1 (de)
ES (1)	ES2316647T3 (de)
WO (1)	WO2003030813A2 (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7314634B2 (en) *	2002-02-22	2008-01-01	Steven Hernandez	Use of polyphenols to treat skin conditions
US7851477B2 (en) *	2003-05-22	2010-12-14	L'oreal	Method for the treatment of skin
US8410102B2 (en)	2003-05-27	2013-04-02	Galderma Laboratories Inc.	Methods and compositions for treating or preventing erythema
US7439241B2 (en) *	2003-05-27	2008-10-21	Galderma Laboratories, Inc.	Compounds, formulations, and methods for treating or preventing rosacea
US20050020600A1 (en)	2003-07-23	2005-01-27	Scherer Warren J.	Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists
WO2005048929A2 (en) *	2003-11-13	2005-06-02	Galileo Pharmaceuticals, Inc.	Plant-derived protein extract compositions and methods
WO2005067627A2 (en) *	2004-01-07	2005-07-28	E-L Management Corporation	Cosmetic composition and method for retarding hair growth
US7812049B2 (en) *	2004-01-22	2010-10-12	Vicept Therapeutics, Inc.	Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists
AU2005203301A1 (en) *	2004-07-30	2006-02-16	Johnson & Johnson Consumer Companies, Inc.	Compositions and methods for treating skin conditions
DE102005005486A1 (de) *	2005-02-04	2006-08-17	Schwan-Stabilo Cosmetics Gmbh & Co. Kg	Zubereitung, insbesondere kosmetische Zubereitung sowie ihre Herstellung und Verwendung
EP1898952B1 (de)	2005-06-17	2012-09-12	Symrise AG	Synergistische mischungen von aromatischen alkoholen und derivaten davon mit tropolon
FR2894821B1 (fr) *	2005-12-15	2008-02-29	Galderma Res & Dev	Compositions comprenant au moins un compose retinoide et au moins un compose anti-irritant et leurs utilisations
US20070166266A1 (en) *	2006-01-19	2007-07-19	Solazyme, Inc.	Methods and compositions for improving the health and appearance of skin
WO2007084769A2 (en) *	2006-01-19	2007-07-26	Solazyme, Inc.	Microalgae-derived compositions for improving the health and appearance of skin
US20070191303A1 (en) *	2006-01-19	2007-08-16	Solazyme, Inc.	Polysaccharide compositions and methods of producing, screening, and formulating polysaccharide compositions
US8298548B2 (en)	2007-07-18	2012-10-30	Solazyme, Inc.	Compositions for improving the health and appearance of skin
US8277849B2 (en) *	2006-01-19	2012-10-02	Solazyme, Inc.	Microalgae-derived compositions for improving the health and appearance of skin
US20090274736A1 (en) *	2006-01-19	2009-11-05	Solazyme Inc.	Nutraceutical Compositions From Microalgae And Related Methods of Production And Administration
US7381433B1 (en) *	2007-01-08	2008-06-03	Johnson & Johnson Consumer Companies, Inc.	Compositions containing an extract of a primula denticulata and use thereof
CA2749750C (en) *	2008-04-15	2014-01-28	Immanence Integrale Dermo Correction Inc.	Skin care compositions and methods of use thereof
EP2116237A1 (de)	2008-08-05	2009-11-11	Polichem SA	Zusammensetzungen enthaltend Chitosan und Dicarboxysäure zur Behandlung von Rosacea
US8927522B2 (en)	2008-10-14	2015-01-06	Solazyme, Inc.	Microalgal polysaccharide compositions
WO2010054322A1 (en)	2008-11-07	2010-05-14	Solazyme, Inc.	Cosmetic compositions comprising microalgal components
EP2329849B1 (de)	2009-11-18	2015-04-29	Galderma Research & Development	Kombination aus einem Alpha-2-Adrenozeptor-Agonisten und einem nichtsteroidalen entzündungshemmenden Mittel zur Behandlung oder Prävention einer Entzündungskrankheit der Haut
US8394800B2 (en) *	2009-11-19	2013-03-12	Galderma Laboratories, L.P.	Method for treating psoriasis
US9629856B2 (en)	2010-03-03	2017-04-25	Anteis Sa	Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds
US9180112B2 (en) *	2010-03-23	2015-11-10	Ermis Labs, LLC	Dermal compositions containing gorgonian extract
EP2552449B1 (de)	2010-03-26	2017-04-19	Galderma Research & Development	Zusammensetzungen mit brimonidin zur behandlung von eines erythems
ES2730411T3 (es)	2010-03-26	2019-11-11	Galderma Res & Dev	Composiciones mejoradas que comprenden brimonidina para un tratamiento seguro y eficaz de la telangiectasia
US8053427B1 (en)	2010-10-21	2011-11-08	Galderma R&D SNC	Brimonidine gel composition
SI2444068T1 (sl)	2010-10-21	2014-11-28	Galderma S.A.	Brimodin gel sestavek
CA2823545C (en)	2010-12-30	2018-11-27	Mary Kay Inc.	Cosmetic compositions for treating a dry skin
US9962361B2 (en)	2011-01-03	2018-05-08	The William M. Yarbrough Foundation	Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US11279674B2 (en)	2011-01-03	2022-03-22	The William M. Yarbrough Foundation	Isothiocyanate functional surfactant and associated method of use
US10647668B2 (en)	2011-01-03	2020-05-12	The William M. Yarbrough Foundation	Isothiocyanate functional surfactant and associated method of use
US10273205B2 (en)	2011-01-03	2019-04-30	The William M. Yarbrough Foundation	Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
US11407713B2 (en)	2011-01-03	2022-08-09	The William M. Yarbrough Foundation	Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US10640464B2 (en)	2011-01-03	2020-05-05	The William M. Yarbrough Foundation	Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
US8933119B2 (en)	2011-01-03	2015-01-13	The William M. Yarbrough Foundation	Method for treating phytophotodermatitis
US10308599B2 (en)	2011-01-03	2019-06-04	The William M. Yarbrough Foundation	Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US8865765B2 (en)	2011-01-12	2014-10-21	The William M. Yarbrough Foundation	Method for treating eczema
US9532969B2 (en)	2011-02-08	2017-01-03	The William M. Yarbrough Foundation	Method for treating psoriasis
WO2013016072A1 (en)	2011-07-22	2013-01-31	Allergan, Inc.	Pharmaceutical compositions comprising 4-bromo-n-(imidazolidin-2-ylidene)-1h-benzimidazol-5-amine for treating skin diseases
AU2012324543B2 (en)	2011-10-19	2017-08-10	Galderma S.A.	Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitors
UA109359C2 (xx)	2011-11-10	2015-08-10		Лікування захворювань і станів шкіри 7-(1h-імідазол-4-ілметил)-5,6,7,8-тетрагідрохіноліном
US9283217B2 (en)	2011-11-10	2016-03-15	Allergan, Inc.	Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
US8877259B2 (en)	2012-02-09	2014-11-04	Mary Kay Inc.	Cosmetic formulation
US10441561B2 (en)	2012-07-26	2019-10-15	The William M. Yanbrough Foundation	Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
US10434082B2 (en)	2012-07-26	2019-10-08	The William M. Yarbrough Foundation	Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms
US10080734B2 (en)	2012-07-26	2018-09-25	The William M. Yarbrough Foundation	Method for treating autism and other neurodevelopmental disorders
US10335387B2 (en)	2012-07-26	2019-07-02	The William M. Yarbrough Foundation	Method for treating infectious diseases with isothiocyanate functional compounds
WO2014018874A1 (en)	2012-07-26	2014-01-30	The William M. Yarbrough Foundation	Method for treating skin cancer
US9839621B2 (en)	2012-07-26	2017-12-12	The William M. Yarbrough Foundation	Method for treating bladder cancer
US9949943B2 (en) *	2012-07-26	2018-04-24	The William M. Yarbrough Foundation	Method for treating neurodegenerative diseases
US10434081B2 (en)	2012-07-26	2019-10-08	The William M. Yarbrough Foundation	Inhibitors of macrophage migration inhibitory factor
US9861645B2 (en)	2012-12-28	2018-01-09	Rak Holdings Llc	Anti-itch scalp treatment compositions and combinations
BR112015028457A8 (pt)	2013-05-15	2017-10-03	Solazyme Inc	Composições cosméticas compreendendo óleo de microalgas
US10251833B2 (en)	2014-07-11	2019-04-09	Mary Kay Inc.	Pore minimizer
GB2528482A (en) *	2014-07-23	2016-01-27	Skintech Life Science Ltd	Pharmaceutical agent
EP3761952A4 (de) *	2018-03-09	2021-12-15	Ocusoft, Inc.	Topische hautpflegezusammensetzungen

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR900007498B1 (ko)	1987-06-18	1990-10-11	구레하 가가꾸 고교 가부시끼가이샤	다당류 및 그것을 활성성분으로 함유하는 항바이러스 약제
US5306486A (en)	1993-03-01	1994-04-26	Elizabeth Arden Co., Division Of Conopco, Inc.	Cosmetic sunscreen composition containing green tea and a sunscreen
FR2732221B1 (fr)	1995-03-28	1997-04-25	Oreal	Utilisation d'un antagoniste de cgrp pour traiter les rougeurs cutanees d'origine neurogene et composition obtenue
US5624911A (en)	1995-06-07	1997-04-29	The Regents Of The University Of California	Ether derivatives of pseudopterosin
IL114267A0 (en)	1995-06-22	1995-10-31	Univ Ben Gurion	Antiviral agents
KR100556682B1 (ko)	1995-09-01	2006-06-21	코스모페름 베.파우	스핑고이드염기의레티노일아미드계유도체
US5885595A (en)	1996-05-13	1999-03-23	Elizabeth Arden Co., Division Of Conopco, Inc.	Cosmetic composition with a retinol fatty acid ester
US5811114A (en)	1996-06-12	1998-09-22	E-L Management Corp.	Stabilized hinokitiol and compositions containing same
US5728732A (en)	1996-11-27	1998-03-17	Elizabeth Arden Company, Division Of Conopco, Inc.	Skin treatment with salicylic acid esters and retinoids
ES2186199T3 (es) *	1997-09-12	2003-05-01	Procter & Gamble	Articulo de limpieza y acondicionador para la piel o el pelo.
KR100639531B1 (ko)	1997-12-05	2006-10-27	코스모페름 베.파우	유리 스핑고이드 염기 및 세라미드의 조합으로 이루어지는 조성물 및 그것의 제조방법
US5972993A (en)	1998-03-20	1999-10-26	Avon Products, Inc.	Composition and method for treating rosacea and sensitive skin with free radical scavengers
BR9911674A (pt)	1998-07-03	2001-03-20	Cosmoferm Bv	Linguagens microbiais aperfeiçoadas produzindo bases efingóides
US5952372A (en)	1998-09-17	1999-09-14	Mcdaniel; William Robert	Method for treating rosacea using oral or topical ivermectin

2001
- 2001-10-05 US US09/971,561 patent/US6680062B2/en not_active Expired - Lifetime
2002
- 2002-09-18 AU AU2002334601A patent/AU2002334601B2/en not_active Ceased
- 2002-09-18 EP EP02800840A patent/EP1441685B1/de not_active Expired - Lifetime
- 2002-09-18 ES ES02800840T patent/ES2316647T3/es not_active Expired - Lifetime
- 2002-09-18 CA CA2461941A patent/CA2461941C/en not_active Expired - Fee Related
- 2002-09-18 JP JP2003533847A patent/JP3921202B2/ja not_active Expired - Fee Related
- 2002-09-18 WO PCT/US2002/029722 patent/WO2003030813A2/en active Application Filing
- 2002-09-18 DE DE60229971T patent/DE60229971D1/de not_active Expired - Lifetime
- 2002-09-18 AT AT02800840T patent/ATE414527T1/de not_active IP Right Cessation
2006
- 2006-08-22 JP JP2006225842A patent/JP2006306899A/ja active Pending

Also Published As

Publication number	Publication date
EP1441685B1 (de)	2008-11-19
CA2461941A1 (en)	2003-04-17
JP3921202B2 (ja)	2007-05-30
EP1441685A4 (de)	2007-10-31
ES2316647T3 (es)	2009-04-16
WO2003030813A3 (en)	2004-03-11
ATE414527T1 (de)	2008-12-15
AU2002334601B9 (en)	2003-04-22
CA2461941C (en)	2011-07-26
WO2003030813A2 (en)	2003-04-17
AU2002334601B2 (en)	2007-01-25
JP2006306899A (ja)	2006-11-09
EP1441685A2 (de)	2004-08-04
US6680062B2 (en)	2004-01-20
US20030068343A1 (en)	2003-04-10
JP2005508936A (ja)	2005-04-07

Legal Events

Date	Code	Title	Description
2009-12-10	8364	No opposition during term of opposition

Publication	Publication Date	Title
DE60229971D1 (de)	2009-01-02	Zubereitungen zur reizhemmenden rosacea-behandlung
BRPI0006634B8 (pt)	2021-05-25	composição tópica compreendendo extrato de matricária no tratamento e prevenção de distúrbios inflamatórios
MEP31508A (en)	2010-10-10	Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
TW200509956A (en)	2005-03-16	Compositions and methods for treatment of rosacea
BRPI0408476A (pt)	2006-04-04	métodos para melhorar a qualidade da pele
ATE361084T1 (de)	2007-05-15	Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
WO2007046097A3 (en)	2009-04-09	Topical compositions for the treatment of depilation-induced skin irritation or prevention thereof
BR0315598A (pt)	2005-09-06	Anticorpos neutralizantes contra gdf-8 e usos dos mesmos
MY160153A (en)	2017-02-28	Process for the preparation of plant extracts for treating skin disorders and enhancing healing of wounds
DE60237115D1 (de)	2010-09-02	Synergistische Kombination von (-) -Gossypol mit Docetaxel oder Paclitaxel zur Behandlung von Krebs.
ATE536185T1 (de)	2011-12-15	Verfahren zur abschwächung von reaktionen auf hautreizende mittel
BR0213100A (pt)	2004-11-30	Combinações para o tratamento de distúrbios imuniinflamatórios
DE602004017871D1 (de)	2009-01-02	Zubereitungen zur behandlung von arthritischen erscheinungen
NO20061236L (no)	2006-06-15	Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og paratyroidhoziiton
ATE234089T1 (de)	2003-03-15	Zubereitungen enthaltend sclareol und sclareolide zur behandlung mikrobieller infektionen
HUP0304077A2 (hu)	2004-03-29	A bőr öregedése elleni gyógyászati és kozmetikai készítmények
ATE318610T1 (de)	2006-03-15	Orale zusammensetzungen zur behandlung von kopfhauterkrankungen
AR004326A1 (es)	1998-11-04	Utilizacion de al menos un antagonista de tnf-alfa, composicion cosmetica, farmaceutica o dermatologica que contiene dicho antagonista y procedimiento detratamiento cosmetico empleando dicho antagonista.
TW200724150A (en)	2007-07-01	Plant extracts for treating skin disorders and enhancing healing of wounds for diabetics patients
DE60134002D1 (de)	2008-06-26	Topische zusammensetzungen zur transdermalen gabe von niacin prodrugs sowie verfahren zur behandlung von hyperlipidämie
WO2003092645A3 (fr)	2004-04-01	Composition cosmetique comprenant des mono- ou poly-saccharides
ATE326947T1 (de)	2006-06-15	Thixotropes nasenspray
BRPI0414786A (pt)	2006-11-21	extrato de mahonia aquifolium, processo de extração e composição farmacêutica contendo o mesmo
WO2002037122A3 (en)	2002-12-27	Sterol glucoside toxins
WO2002087533A8 (de)	2003-01-09	Verwendung von klee-extrakt zur prophylaxe gegen und behandlung von degenerativen hauterscheinungen